[Contrast media-induced nephropathy: clinical burden and current attempts for prevention].
Contrast media-induced nephropathy is the third most common cause of hospital acquired acute renal failure. With the increasing use of contrast media in diagnostic and interventional procedures it has become one of the major challenges encountered during routine cardiology practice. Despite clinical importance it is an under-recognized event with major morbidity and mortality. Risk of developing contrast media-induced nephropathy depends mainly on patients preexisting characteristics and physicochemical properties of the contrast agent. Primary attempts for the prevention of contrast media-induced nephropathy should include systematic review of patient's characteristics and risk stratification. Patients at the greatest risk for contrast media-induced nephropathy can be defined as those having preexisting impaired renal function, diabetes mellitus, and congestive heart failure. Other risk factors include; age above seventy years, female gender, dehydration and use of high volume contrast media. The more expeditious use of iso-osmolar non-ionic contrast media reduced the incidence of contrast media related renal dysfunction. Currently, the only widely proven method of reducing the risk of contrast-induced nephropathy is adequate pre and postprocedural hydration. In addition, prophylactic use of free radical scavenger N-acetylcysteine has been shown to prevent contrast media-induced nephropathy in some moderate-scale clinical trials and a meta-analysis. Despite the attempts to reduce the risk of contrast nephropathy, this clinical event affects over 25% of high risk patients and mortality remains to be high.
Habeb
Muhammed
M
Department of Cardiology, Cerrahpaşa Medical Faculty, Istanbul University, Fatih, Istanbul, Turkey.
Ağaç
Mustafa Tarik
MT
Aliyev
Farid
F
Pehlivanoğlu
Seçkin
S
Ongen
Zeki
Z
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000517:prevention & control*; D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging*; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D011859:Radiography; D018570:Risk Assessment
D003287:Contrast Media